Importantly, the reduced frequencies of activated CD8+ and CD4+ Teff cells observed, in vitro, in PBMC of patients affected by thyroid cancer associated with autoimmune thyroiditis at time of analysis, do not foresee progression of autoimmune responses post-thyroidectomy in vivo during the follow-up. This evidence concerns the gene CD8A and thyroid cancer.